Archive January 6, 2020 Deciphera Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference
Archive December 16, 2019 Deciphera Pharmaceuticals Announces Submission of New Drug Application to U.S. FDA for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors
Archive December 4, 2019 Deciphera Pharmaceuticals Announces Appointment of Ron Squarer to its Board of Directors
Archive November 26, 2019 Deciphera Pharmaceuticals Expands its Board of Directors with Appointment of Frank S. Friedman
Archive November 13, 2019 Deciphera Pharmaceuticals, Inc. to Present Data from DCC-3014 and Ripretinib Programs at the Connective Tissue Oncology Society (CTOS) 2019 Annual Meeting
Archive November 13, 2019 Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
Archive November 4, 2019 Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2019 Financial Results
Archive October 29, 2019 Deciphera Pharmaceuticals Presents Updated Data from Ripretinib and DCC-3014 Programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Archive October 28, 2019 Deciphera Pharmaceuticals Presents Data from Rebastinib and DCC-3116 Programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Archive October 28, 2019 Deciphera Pharmaceuticals, Inc. to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 4, 2019
